Skip to main content

Obstructive Sleep Apnea of Adult

1
Pipeline Programs
6
Companies
10
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Idorsia
IdorsiaSwitzerland - Allschwil
1 program
1
DaridorexantPhase 11 trial
Active Trials
NCT05458193Completed20Est. Feb 2023
Cryosa
CryosaBRENTWOOD, TN
3 programs
CHILLS ProcedureN/A1 trial
CHILLS ProcedureN/A1 trial
Cryosa ProcedureN/A1 trial
Active Trials
NCT04864652Completed84Est. May 2023
NCT05542082Terminated22Est. Sep 2023
NCT06008626Recruiting25Est. Jun 2028
Nyxoah
NyxoahBelgium - Mont-Saint-Guibert
2 programs
GenioN/A1 trial
Genio SystemN/A1 trial
Active Trials
NCT03048604Completed27Est. Sep 2018
NCT05939141Not Yet Recruiting39Est. Jul 2029
Philips
PhilipsNetherlands - Amsterdam
2 programs
Positional deviceN/A1 trial
structured adherence management programN/A1 trial
Active Trials
NCT05268471Unknown154Est. Dec 2024
NCT03243487Completed250Est. May 2019
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Continuous Positive Airway PressureN/A1 trial
Active Trials
NCT03487185Recruiting1,500Est. Dec 2026
Verily Life Sciences
1 program
Verily Sleep ApneaN/A1 trial
Active Trials
NCT04599803Completed187Est. Mar 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
IdorsiaDaridorexant
NyxoahGenio System
CryosaCryosa Procedure
PhilipsPositional device
CryosaCHILLS Procedure
CryosaCHILLS Procedure
Verily Life SciencesVerily Sleep Apnea
Human BioSciencesContinuous Positive Airway Pressure
Philipsstructured adherence management program
NyxoahGenio

Clinical Trials (10)

Total enrollment: 2,308 patients across 10 trials

NCT05458193IdorsiaDaridorexant

A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep

Start: Aug 2022Est. completion: Feb 202320 patients
Phase 1Completed
NCT05939141NyxoahGenio System

An Extension Study to Assess the Long-term Safety of the Genio® System

Start: Nov 2025Est. completion: Jul 202939 patients
N/ANot Yet Recruiting
NCT06008626CryosaCryosa Procedure

Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

Start: Sep 2023Est. completion: Jun 202825 patients
N/ARecruiting
NCT05268471PhilipsPositional device

Cost-effectiveness Analysis and Conditional Response to the Effect of Positional Devices in Obstructive Sleep Apnea

Start: Oct 2022Est. completion: Dec 2024154 patients
N/AUnknown
NCT05542082CryosaCHILLS Procedure

Pilot Study of the CHILLS Cryotherapy System for the Treatment of OSA

Start: Aug 2022Est. completion: Sep 202322 patients
N/ATerminated
NCT04864652CryosaCHILLS Procedure

Safety and Dosing Study of the CHILLS Cryotherapy for the Treatment of OSA

Start: Nov 2020Est. completion: May 202384 patients
N/ACompleted

Baseline Sleep Apnea Study #2

Start: Jul 2020Est. completion: Mar 2021187 patients
N/ACompleted
NCT03487185Human BioSciencesContinuous Positive Airway Pressure

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

Start: Aug 2018Est. completion: Dec 20261,500 patients
N/ARecruiting
NCT03243487Philipsstructured adherence management program

ThErapy Adherence Management in Veterans

Start: Aug 2017Est. completion: May 2019250 patients
N/ACompleted

BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnoea (BLAST OSA)

Start: Mar 2017Est. completion: Sep 201827 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 2,308 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.